Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low‐dose acetylsalicylic acid (ASA) compared with SSRI or low‐dose ASA alone—A systematic review and meta‐analysis

Documents similaires

• Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study
  par: Jean‐Louis Montastruc, et autres
  Publié: (2024)
• Quantifying serotonin in four aquatic invertebrates using enzyme-linked immunosorbent assays (ELISA): Implications for assessing selective serotonin reuptake inhibitor (SSRI) effects.
  par: Lautrette-Quinveros, Harmony, et autres
  Publié: (2026)
• Pharmacological treatment with a GABA(A) receptor modulator and a selective serotonin reuptake inhibitor as a mitigation strategy against aircraft noise‐induced cardiovascular and neuronal damage
  par: Ivana Kuntić, et autres
  Publié: (2026)
• Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis
  par: Magnus A. B. Axelsson, et autres
  Publié: (2025)
• Ileal bile acid transporter inhibitors in Alagille syndrome and Progressive Familial Intrahepatic Cholestasis: A systematic review into dose–response
  par: Alise D. E. de Groot, et autres
  Publié: (2025)